On 10 March 2022, the <a href="https://www.europarl.europa.eu/news/en/press-room/20220304IPR24801/three-new-committees-on-pegasus-spyware-foreign-interference-and-covid-19" style="color:blue; text-decoration:underline" target="_blank">European Parliament established</a> a new special committee on the COVID-19 pandemic, composed of 38 members. The committee is set up for a 12-month term, running from the date of its constitutive meeting, and may be extended.&nbsp;

The majority of the special committee’s work will focus on four pandemic-related areas: health; a coordinated response respecting democracy and fundamental rights; the societal and economic impact; and the EU and the world.

The COVI Chair Kathleen Van Brempt said: “Although this pandemic has not yet ended, Europe already finds itself in the next crisis. In the past fifteen years, the EU has weathered a financial crisis, a refugee crisis, a pandemic, and now a war. Through these crises, we saw the EU often lacked the necessary tools to act quickly. We saw member states only agreeing a European response when it was already too late, be it on the joint procurement of medical equipment, a common European migration policy, or the deepening of the Energy Union. This has brought us the European Union we know today: one that can react to crises, but lacks the political mandate to prepare for them.&nbsp;We need to fundamentally change this dynamic. This is exactly what Parliament’s COVI committee will try to achieve: building a Europe that is better prepared for future crises by drawing lessons from the pandemic. Because COVID-19 was also a crisis of rising inequality, of the economy, our democracy &amp; fundamental rights, and of international governance, the COVI committee will consider the impact of the pandemic on all aspects of society."

COVI - Special Committee on the EU's response to the COVID-19 pandemic

COVI Special Committee - Exchange of views with Emer Cooke, Executive Director of the European Medicines Agency (EMA)

Special Committee on COVID-19 pandemic

COVI - Policy department A

MEPs from the COVI Committee (Special Committee on the COVID-19 pandemic: lessons learned and recommendations for the future) exchange with Stella KYRIAKIDES, Commissioner for Health, Food and Safety Commissioner on new regulation on cross-border threats to health, a new EU network of reference laboratories, the long-Covid side effects and the transparency around vaccines contracts. In a second part, they exchange with Emer COOKE, Executive Director of the European Medicines Agency on the recommendations to strengthen EMA’s response to future public health emergencies. Extracts.

Exchange of views with Stella KYRIAKIDES, European Commissioner for Health and Food Safety and with Emer COOKE, Executive Director of the European Medicines Agency (EMA): extracts - COVI Committee

&lt;p>MEPS from the COVI Committee talk with representatives from pharmaceutical companies that worked on developing vaccines and therapeutics during the COVID-19 pandemic. Dr Rudolf Ertl, Senior Vice-President Commercial Operations (Gilead Sciences), Thomas Triomphe, Executive Vice-President of Vaccines (Sanofi), Iskra Reic, Executive Vice-President of Europe and Canada, (AstraZeneca) and Stéphane Bancel, Chief Executive Officer, (Moderna) participate to the debate.&lt;/p>

COVID-19 - debate with the pharmaceutical industry: extracts from the exchange of views with representatives from Gilead Sciences, Sanofi, AstraZeneca and Moderna

Special Committee’s on the COVID-19 pandemic holds an exchange of views with Sandra Gallina, Director-General for Health and Food Safety. MEPs discuss the main challenges that the EU and its Member States faced in handling the COVID-19 pandemic, the health issues, how Advanced Purchase Agreements were drawn up, and the lessons learned for the future. Kathleen VAN BREMPT (S&D,BE), COVI Chair and Kathleen VAN BREMPT (S&D,BE) issues a statement.

COVID-19 pandemic: lessons learned and recommendations for the future - statement by Kathleen VAN BREMPT (S&D,BE), COVI Chair

The Special Committee on the COVID-19 pandemic will holds its constitutive meeting.The new special committee focusing on the COVID-19 pandemic, composed of 38 members. The special committee has been tasked with looking into how the European response to the pandemic and the lessons learned can contribute to future action in the following areas: health; a coordinated approach with respect for democracy and fundamental rights; societal and economic impact; and EU and the World. The special committee will have twelve months to compile its recommendations. Elections of the Special Committee (COVI), Kathleen VAN BREMPT, as Chair of COVI (S&amp;D), GLÜCK, Andreas (rRenew), as Vice-chair of COVI, KOPACZ, Ewa, (PPE) as Vice-chair of COVI, RIVASI, Michèle, (Greens), as chair of COVI, KARSKI, Karol, (ECR) as Vice-chair of COVI

Special Committee on the COVID-19 pandemic: lessons learned and recommendations for the future (COVI): atmosphere shots of the constitutive meeting and statement

574 results for "COVI"

Topics (1)

COVI - Special Committee on the EU's response to the COVID-19 pandemic

Streaming (34)

Videos (4)

Exchange of views with Stella KYRIAKIDES, European Commissioner for Health and Food Safety and with Emer COOKE, Executive Director of the European Medicines Agency (EMA): extracts - COVI Committee

COVID-19 - debate with the pharmaceutical industry: extracts from the exchange of views with representatives from Gilead Sciences, Sanofi, AstraZeneca and Moderna

COVID-19 pandemic: lessons learned and recommendations for the future - statement by Kathleen VAN BREMPT (S&D,BE), COVI Chair

Special Committee on the COVID-19 pandemic: lessons learned and recommendations for the future (COVI): atmosphere shots of the constitutive meeting and statement

Photos (535)

COVI Special Committee - Exchange of views with Emer Cooke, Executive Director of the European Medicines Agency (EMA)

COVI Special Committee - Exchange of views with Emer Cooke, Executive Director of the European Medicines Agency (EMA)

COVI Special Committee - Exchange of views with Emer Cooke, Executive Director of the European Medicines Agency (EMA)

COVI Special Committee - Exchange of views with Emer Cooke, Executive Director of the European Medicines Agency (EMA)

COVI Special Committee - Exchange of views with Emer Cooke, Executive Director of the European Medicines Agency (EMA)

COVI Special Committee - Exchange of views with Emer Cooke, Executive Director of the European Medicines Agency (EMA)